These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia. Cooper MR, Durand CR, Beaulac MT, Steinberg M. Ann Pharmacother; 2011 Sep 20; 45(9):1094-102. PubMed ID: 21862714 [Abstract] [Full Text] [Related]
8. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia]. Karthaus M, Meran JG, Geissler RG, Böhme A, Jürgens H, Ganser A. Wien Med Wochenschr; 1998 Sep 20; 148(18):427-32. PubMed ID: 9888179 [Abstract] [Full Text] [Related]
10. [A general description of the clinical guideline for the management of febrile neutropenia]. Takamatsu Y. Gan To Kagaku Ryoho; 2013 Jun 20; 40(6):697-702. PubMed ID: 23863646 [Abstract] [Full Text] [Related]
11. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA. Cancer; 2005 Jun 15; 103(12):2629-35. PubMed ID: 15856427 [Abstract] [Full Text] [Related]
13. Febrile neutropenia in French emergency departments: results of a prospective multicentre survey. André S, Taboulet P, Elie C, Milpied N, Nahon M, Kierzek G, Billemont M, Perruche F, Charpentier S, Clément H, Pourriat JL, Claessens YE. Crit Care; 2010 Jun 15; 14(2):R68. PubMed ID: 20403164 [Abstract] [Full Text] [Related]
14. Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia. Bash RO, Katz JA, Cash JV, Buchanan GR. Cancer; 1994 Jul 01; 74(1):189-96. PubMed ID: 8004575 [Abstract] [Full Text] [Related]
16. Implementation of risk stratified antibiotic therapy for neutropenic fever: what are the risks? Wierema J, Konecny P, Links M. Intern Med J; 2013 Oct 01; 43(10):1116-24. PubMed ID: 23869563 [Abstract] [Full Text] [Related]
17. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice. Kumar P, Bajpai J, Shetty N, Medekar A, Kurkure PA, Ghadyalpatil N, Gupta S, Noronha V, Kanujia A, Parikh P, Banavali SD. Indian J Cancer; 2014 Oct 01; 51(4):491-5. PubMed ID: 26842174 [Abstract] [Full Text] [Related]
18. [Antimicrobial prophylaxis and therapy in neutropenia]. Link H. Mycoses; 2003 Oct 01; 46 Suppl 2():21-32. PubMed ID: 15055140 [Abstract] [Full Text] [Related]
19. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV. Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572 [Abstract] [Full Text] [Related]
20. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients. Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T. Med Pediatr Oncol; 2003 Feb 01; 40(2):93-8. PubMed ID: 12461792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]